Skip to content

Rigora Clinical

11 viewers · 30d

Total raised

$305K

+$305K this year

3 filings since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $305K
ROUNDS
3
INVESTORS
4
FOUNDED
2026
HQ
Glendale, CA
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
11

AI overview

Updated

Rigora Clinical builds AI-enabled clinical trial monitoring software that runs source data verification and source data review continuously between site visits rather than in batches before each visit. The system ingests source documents such as lab reports, visit records and certified copies as they are produced, reconciles them against the eCRF, flags discrepancies, and drafts queries and monitoring visit reports for a CRA to review and sign. It is read-only toward EDC and EHR systems and keeps an append-only audit trail with per-value provenance, so every figure shows its source and every state-changing action is attributed. The product is sold primarily to contract research organizations, including as a white-labeled capability under the CRO's own brand.

What sets it apart

Continuous, deterministic SDV/SDR that requires no EDC or EHR integration to start and never writes back to those systems, paired with full provenance, an append-only audit trail and mandatory named human sign-off on every AI-drafted report, positioned against ICH E6(R3) and ISO 14155 risk-based monitoring rather than as autonomous decision-making.

Funding history

3 rounds
Equity+1Jul 16, 2026
Form D
+$50K$305K total
Equity+1Jul 16, 2026
Form D/A
+$250K$305K total
Equity+1Jul 16, 2026
Form D/A
+$305K$305K total

Products

1 tracked

Rigora

Clinical trial monitoring software

An AI-native clinical monitoring layer that continuously reconciles site source documents against the eCRF, flags discrepancies, and drafts queries and monitoring visit reports (MVRs) for CRAs to review, edit and sign.

  • Continuous source data verification and source data review between site visits
  • Automatic reconciliation of source documents against the eCRF with discrepancy flagging
  • Drafted queries and monitoring visit reports that a named reviewer must edit and approve
  • Read-only architecture that never writes to EDC or EHR systems